Yuvaraj Ravikumar

Dr. Yuvaraj Ravikumar


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YRYuvaraj Ravikumar
Yuvaraj Ravikumar
SRSirajunnisa Abdul Razack
Sirajunnisa Abdul Razack
SSShilpa Sivashankar
Shilpa Sivashankar
SSSirichai Srichairatanakool
Sirichai Srichairatanakool
PKPimpisid Koonyosying
Pimpisid Koonyosying
SSSomdet Srichairatanakool
Somdet Srichairatanakool
Hepatocellular carcinoma (HCC) is one of the life–threatening cancers in the current decade. Earlier reports suggest that protein arginine methyl transferase 5 (PRMT5) is also linked with HCC, and the symmetrically dimethylated arginine marks created by PRMT5 are read by the Staphylococcal nuclease domain-containing protein 1 (SND1), which eventually can drive HCC development. Indeed, as no inhibitors have been ascertained for SND1, we aimed to screen for new inhibitors with specificity and high affinity towards the active site of SND1. In this study, we first used the Gene Set Cancer Analysis (GSCA) dataset to evaluate the expression of SND1 in HCC. Accordingly, SND1 is the highly overexpressed gene in HCC and its overexpression affects the overall survival of HCC patients. Then, we employed a virtual screening approach to identify potential inhibitors from the ASINEX database. We utilized molecular docking to single out the potential top hits based on the docking score and mode of interaction with the SND1 active site. In the prediction, we found [4–(5,6,7,8–tetrahydro–4 H–cyclohepta[c][1,2]oxazol–3–yl)piperidin–1–yl]–[4–(trifluoromethyl)phenyl]methanone (TOP1: -10.4 kcal/mol) and 1–[2–hydroxy–2–(1–methylsulfonyl–3,4–dihydro–2 H–quinolin–6–yl)ethyl]–4–(4–methylphenyl)piperidin–4–ol (TOP2: -10.3 kcal/mol) as promising candidates than reference compound (STD: -4.6 kcal/mol). Further molecular dynamics simulations and a pharmacokinetic properties study indicate that TOP2 exhibits a more stable binding with the SND1 active site and complies with Lipinski’s rule of five for drug-likeness, with no observed toxicity and good pharmacokinetic properties.

18 May 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
WPWarinda Prommachote
Warinda Prommachote
MDManu Deeudom
Manu Deeudom
PKPimpisid Koonyosying
Pimpisid Koonyosying
PSPhronpawee Srichomphoo
Phronpawee Srichomphoo
RSRatchanee Somnabut
Ratchanee Somnabut
SSSomdet Srichairatanakool
Somdet Srichairatanakool
Background/Objective:Staphylococcus aureus produces staphyloferrin A (Sfna) siderophores to sequester host iron during infection and rapid cell proliferation We examined drug susceptibility, siderophore production, and genome sequencing of clinical isolates of S. aureus. Methods: A total of 100 specimens, including pus, sputum, hemoculture, urine, tissue, fluid, and skin scrap specimens, were grown in iron-deprived Luria broth agar. The isolates were investigated for spectral signature using MALDI–TOF/MS, while antibiotic susceptibility and siderophore content were assessed using the chrome azurol S method. Whole genome and partial 16S rRNA DNA sequences were employed, and VITEK/MS revealed specific spectra. Results: Clindamycin, erythromycin, gentamicin, linezolid, moxifloxacin, oxacillin, trimethoprim/sulfamethoxazole, and vancomycin (100%) were the most common antibiotics to which the S. aureus isolates were susceptible. Sfna was not detectable in fluid and skin scrap isolates, which were encoded by sfnaB, sfnaD, and sfnaB/sfnaD genes. However, they were detectable in pus (73.8%), sputum (85.3%), hemoculture (50.0%), and urine (85.7%) isolates. The aureus subspecies, JKD6159, SA268, and MN8, were found to be 72.73% according to genome sequencing. Conclusion: most staphylococci in the isolates, including S. aureus JKD6159, SA268, and MN8, were sensitive to antibiotics and were detected by MALDI–TOF/MS, resulting in the production of Sfna encoded by sfna genes.

2 July 2026
Verified
Book Chapter
Closed access
PDF file
ANAishwarya K. Naggol
Aishwarya K. Naggol
SRSirajunnisa Abdul Razack
Sirajunnisa Abdul Razack
YRYuvaraj Ravikumar
Yuvaraj Ravikumar

Verified
Journal Article
Open access
PDF file
Maruthi Prasad YMaruthi Prasad Y
Maruthi Prasad Y
SGSneha Ramaiah Gowda
Sneha Ramaiah Gowda
NSNandita Shantamurthy
Nandita Shantamurthy
ASAllwin Ebinesar Jacob Samuel Sehar
Allwin Ebinesar Jacob Samuel Sehar
SRSirajunnisa Abdul Razack
Sirajunnisa Abdul Razack
YRYuvaraj Ravikumar
Yuvaraj Ravikumar
The presence of an unbalanced gut microbiome and the dysregulation of bile acid signalling are considered pivotal causes of various inflammation-based diseases. The Takeda G protein-coupled receptor (TGR5), TGR5 is a bile acid-responsive receptor that modulates inflammatory signalling pathways, making it an enticing molecular target for the discovery of novel anti-inflammatory agents. Herein, a comprehensive in silico approach was employed to identify potential TGR5 agonists from sterol-rich phytocompounds present in Triphala, a traditional polyherbal formulation. Using in silico computational methods, such as molecular docking and molecular dynamics simulations (MDS), we screened the putative agonistic potential of 10 phytocompounds obtained from Terminalia chebula, Terminalia bellirica, and Phyllanthus emblica against the crystal structure of human TGR5 (PDB ID: 7XTQ). Based on binding energy and molecular interactions, ergosterol (−12.34 ± 0.17 kcal/mol) and stigmasterol (−10.35 ± 0.04 kcal/mol) were predicted to be the top and best compounds. Furthermore, the stability of these two compounds in the docked complex was analysed using MDS for 200 ns. The mean Cα RMSD values were 0.22 ± 0.02 nm for both ergosterol- and stigmasterol-bound complexes, compared to 0.21 ± 0.02 nm for the unbound apo protein. Further, the molecular mechanics/Poisson–Boltzmann surface area (MMPBSA) analysis revealed that ergosterol exhibited binding free energy (−139.868 ± 12.318 kJ/mol) comparable to that of the co-crystallised ligand R399 −93.424 ± 8.919 kJ/mol. In silico ADMET predictions indicated acceptable drug-like properties and low toxicity for both compounds. Collectively, these computational findings suggest that ergosterol is a promising putative TGR5 agonist, warranting further experimental validation of its potential role in modulating inflammation-related pathways.

Verified
Journal Article
Open access
PDF file
WPWarinda Prommachote
Warinda Prommachote
MDManu Deeudom
Manu Deeudom
HMHridek Manimaran
Hridek Manimaran
JKJittasak Khowsathit
Jittasak Khowsathit
PKPimpisid Koonyosying
Pimpisid Koonyosying
SSSomdet Srichairatanakool
Somdet Srichairatanakool
The increasing prevalence of multidrug-resistant Staphylococcus aureus (MRSA) has necessitated the development of alternative therapeutic strategies targeting bacterial virulence factors. This study employed an integrated in silico approach to identifying potential inhibitors of the iron-regulated surface determinant B Near-iron Transporter domain, a key protein involved in heme acquisition and pathogenicity. Virtual screening and molecular docking identified certain similarity-selected small molecules possessing strong binding affinities, with (4-(1-oxoisoindolin-2-yl)benzoic acid (TOP1) and (4-(2-oxochromen-3-yl)benzoic acid (TOP2) exhibiting the most favorable binding energies at −12.0 and −11.8 kcal/mol, respectively. Molecular dynamics simulations over 200 ns confirmed stable protein–ligand interactions that yielded reduced structural fluctuations in ligand-bound complexes when compared with the apo form. Molecular mechanics/Poisson-Boltzmann surface area (MM/PBSA) analysis revealed that van der Waals interactions were the primary contributors to binding, with TOP1 showing a more favorable overall binding energy. Drug-likeness and pharmacokinetic predictions indicated compliance with Lipinski’s rule of five and moderate bioavailability, although limited intestinal absorption was observed. Toxicity predictions indicated that both compounds are non-mutagenic but may exhibit hepatotoxicity. Notably, TOP1 exhibited potential nephrotoxicity, cardiotoxicity, and carcinogenicity, whereas TOP2 demonstrated a more favorable safety profile. These findings highlight a trade-off between binding affinity and safety, suggesting that TOP2 emerged as a computationally prioritized candidate for future experimental validation. Because the present findings represent computational predictions only, further orthogonal computational analyses and experimental studies are required to confirm the proposed binding modes, biological activity, and therapeutic potential of the identified compounds.